AU734794B2 - Agent for preventing and/or treating renal disease - Google Patents

Agent for preventing and/or treating renal disease Download PDF

Info

Publication number
AU734794B2
AU734794B2 AU64208/98A AU6420898A AU734794B2 AU 734794 B2 AU734794 B2 AU 734794B2 AU 64208/98 A AU64208/98 A AU 64208/98A AU 6420898 A AU6420898 A AU 6420898A AU 734794 B2 AU734794 B2 AU 734794B2
Authority
AU
Australia
Prior art keywords
ala
tcf
lys
mutant
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU64208/98A
Other languages
English (en)
Other versions
AU6420898A (en
Inventor
Kanji Higashio
Masahiko Kinosaki
Fumie Kobayashi
Hiroaki Masunaga
Hiromi Ogawa
Kyoji Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atlas Pharmaceuticals Inc
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of AU6420898A publication Critical patent/AU6420898A/en
Application granted granted Critical
Publication of AU734794B2 publication Critical patent/AU734794B2/en
Assigned to DAIICHI PHARMACEUTICAL CO., LTD. reassignment DAIICHI PHARMACEUTICAL CO., LTD. Alteration of Name(s) in Register under S187 Assignors: SNOW BRAND MILK PRODUCTS CO., LTD.
Assigned to DAIICHI SANKYO COMPANY, LIMITED reassignment DAIICHI SANKYO COMPANY, LIMITED Request to Amend Deed and Register Assignors: DAIICHI PHARMACEUTICAL CO., LTD.
Assigned to ATLAS PHARMACEUTICALS INC. reassignment ATLAS PHARMACEUTICALS INC. Alteration of Name(s) in Register under S187 Assignors: DAIICHI SANKYO COMPANY, LIMITED
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU64208/98A 1997-03-28 1998-03-20 Agent for preventing and/or treating renal disease Ceased AU734794B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9-94989 1997-03-28
JP09498997A JP3961064B2 (ja) 1997-03-28 1997-03-28 腎疾患予防及び／又は治療剤
PCT/JP1998/001221 WO1998043665A1 (fr) 1997-03-28 1998-03-20 Agent preventif et/ou therapeutique pour les maladies des reins

Publications (2)

Publication Number Publication Date
AU6420898A AU6420898A (en) 1998-10-22
AU734794B2 true AU734794B2 (en) 2001-06-21

Family

ID=14125298

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64208/98A Ceased AU734794B2 (en) 1997-03-28 1998-03-20 Agent for preventing and/or treating renal disease

Country Status (7)

Country Link
US (1) US6306827B1 (enExample)
EP (1) EP0925791A4 (enExample)
JP (1) JP3961064B2 (enExample)
AU (1) AU734794B2 (enExample)
CA (1) CA2253929A1 (enExample)
WO (1) WO1998043665A1 (enExample)
ZA (1) ZA982606B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531673T2 (de) * 1994-12-27 2004-07-08 Daiichi Pharmaceutical Co., Ltd. Tcf mutante
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ES2274567T3 (es) 1997-03-14 2007-05-16 Daiichi Pharmaceutical Co., Ltd. Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.
JP4252591B2 (ja) * 2006-08-08 2009-04-08 クロリンエンジニアズ株式会社 オゾン製造装置

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0640935A (ja) * 1992-07-16 1994-02-15 Snow Brand Milk Prod Co Ltd Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
WO1996020214A1 (en) * 1994-12-27 1996-07-04 Snow Brand Milk Products Co., Ltd. Tcf mutant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468400A (en) 1987-09-09 1989-03-14 Sapporo Breweries Human tumor cytotoxic factor htcf, production thereof and antitumor agent comprising said factor as active ingredient
CA2100720C (en) * 1992-07-16 2003-03-11 Hiroaki Masunaga Medicinal composition comprising tcf-ii

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0640935A (ja) * 1992-07-16 1994-02-15 Snow Brand Milk Prod Co Ltd Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
WO1996020214A1 (en) * 1994-12-27 1996-07-04 Snow Brand Milk Products Co., Ltd. Tcf mutant

Also Published As

Publication number Publication date
JP3961064B2 (ja) 2007-08-15
US6306827B1 (en) 2001-10-23
JPH10273446A (ja) 1998-10-13
EP0925791A4 (en) 2004-06-16
ZA982606B (en) 1998-09-30
WO1998043665A1 (fr) 1998-10-08
AU6420898A (en) 1998-10-22
EP0925791A1 (en) 1999-06-30
CA2253929A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
KR102777151B1 (ko) 인터루킨-2의 부분 효능제
DK2633865T3 (en) USE OF INTERLEUKIN-22 IN THE TREATMENT OF VIRAL HEPATITIS
KR20130091346A (ko) 암 및 만성 감염 치료를 위한, 효능제 활성을 갖는 인터루킨 2로부터 유도된 폴리펩티드
CN104710535B (zh) 重组人g-csf二聚体及其在治疗神经系统疾病中的用途
EP2450442B1 (en) Compositions and methods of using chondroitinase abci mutants
US10363306B2 (en) Cytokines and neuroantigens for treatment of immune disorders
KR20000016159A (ko) 락토페린 변이체와 이의용도
CN104066440A (zh) 白介素-22在治疗和预防神经损伤疾病或神经退行性疾病中的用途
AU734794B2 (en) Agent for preventing and/or treating renal disease
EP1809660B1 (en) A thymus-specific protein
US20170065684A9 (en) Phenotypic reversion of pancreatic carcinoma cells
CN108295242B (zh) 用于预防和/或治疗银屑病药物组合物、cd317胞外段蛋白的应用
JPH083058A (ja) 新規な骨代謝疾患治療剤
KR100552434B1 (ko) 신질환 예방 및/또는 치료제_
CN119874872B (zh) 一种mita铰链区突变多肽及其在自身免疫性疾病中的应用
US20080286227A1 (en) Use of Il-17F for the Treatment and/or Prevention of Neurologic Diseases
CN101555284A (zh) 截短型人睫状神经营养因子活性片段及其融合蛋白
Bakhiet Cytokines as Novel Therapeutic Agents for Neuroinflammatory Disorders: A Role for Interferon- in the Treatment of Multiple Sclerosis
HK1185552B (en) Use of interleukin-22 in treating viral hepatitis
HK1110870B (en) Deglycosylated and desialidated long pentraxin ptx3

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: DAIICHI PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER WAS: SNOW BRAND MILK PRODUCTS CO., LTD.